Triple

T10502806
Position Surface form Disambiguated ID Type / Status
Subject Established Pharmaceuticals E247711 entity
Predicate competitors P1375 FINISHED
Object Sandoz E584145 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Sandoz | Statement: [Established Pharmaceuticals, competitors, Sandoz]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Sandoz
Context triple: [Established Pharmaceuticals, competitors, Sandoz]
  • A. Sandoz chosen
    Sandoz is a historic Swiss pharmaceutical company best known as a predecessor of Novartis and a major player in generic medicines.
  • B. Novartis
    Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
  • C. Roche
    Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
  • D. Roche
    Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
  • E. Mylan
    Mylan is a global generic and specialty pharmaceuticals company known for producing a wide range of affordable medicines and healthcare products.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: competitors
Context triple: [Established Pharmaceuticals, competitors, Sandoz]
  • A. competitionFrom
    Indicates that one entity is experiencing competitive pressure or rivalry originating from another entity.
  • B. competesWith chosen
    Indicates that two entities are in rivalry or opposition, each striving to outperform or gain advantage over the other in the same domain or objective.
  • C. competitionOf
    Indicates a relationship where one entity is the competitive event, contest, or rivalry involving another entity.
  • D. tieneCompetenciaEn
    Indicates that an entity possesses skill, expertise, or competence in a specific area, field, or activity.
  • E. competition
    Indicates a relationship where two or more entities strive against each other to achieve a superior outcome, advantage, or reward.
  • F. None of above.

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d381c4aa948190942e1d803143fb0e completed April 6, 2026, 9:49 a.m.
NER Named-entity recognition batch_69d5099c6a848190bf1d5361e9e61108 completed April 7, 2026, 1:41 p.m.
NED1 Entity disambiguation (via context triple) batch_69d97a05ffdc8190a69b39c807a06042 completed April 10, 2026, 10:30 p.m.
PD Predicate disambiguation batch_69d4fb8e24ac8190912c9f11b8bd3084 completed April 7, 2026, 12:41 p.m.
Created at: April 6, 2026, 12:25 p.m.